With a view of reducing the risk of child sexual abuse, Swedish researchers have decided to take a step forward by examining the effectiveness of a drug which could prevent paedophiles from committing crime.
‘A unique trial conducted at The Karolinska Institute in Stockholm, involved the use of a testosterone-suppressing drug as a preventative measure on patients who were seeking help for paedophile fantasies’, as reported by The Independent.
Patients at the Karolinska Institute who have had paedophilic fantasies in the past, but have not reacted to them, are being given a drug which is normally used to treat advanced prostate cancer. This should help see if it reduces the risk of them sexually abusing a child.
Christoffer Rahm is the initiator and the principal investigator for this treatment study.
“This project aims to reduce the number of child sexual abuse cases. In order to achieve this, we are exploring one of the few feasible strategies to establish a preventive, effective and risk reducing treatment for men with paedophilic disorder that is also tolerable for the patient,” stated by the researchers on the British science crowdfunding platform Walacea for raising a portion of the research fund.
“In addition to providing better treatment options to patients with paedophilic disorder, we aim to introduce a reliable objective risk assessment tool. We want to shift focus from what happens when the damage is already done, and instead focus on the earlier phase to intervene before the child sexual abuse happens in the first place,” they added.
This crowdfunding campaign that concludes on July 7, 2016 plans to raise funds for the first part of this project which is the clinical trial, to test the effectiveness of the drug degarelix.
This is a trial of 60 patients, out of which 30 receive an injection of the drug Degarelix and the remaining number is given a placebo.
‘Trial volunteers will be studied for the next two to three years’, the report added.